Cost-effectiveness of chelation therapy with deferasirox versus deferoxamine in transfusion-dependent myelodysplastic syndrome
Policy Analysis Inc. (PAI), Four Davis Court, Brookline, MA 02445 USA. tdelea@pai2.com
Haematologica. 2006;91((Suppl 1):): Abstract No. 0952.